Overexpression of lncRNA WWTR1‐AS1 associates with tumor aggressiveness and unfavorable survival in head‐neck squamous cell carcinoma

Abstract

Long noncoding RNAs (lncRNAs) have been recognized as novel biomarkers and therapeutic targets in human cancer including head‐neck squamous cell carcinoma (HNSCC). Here, we aimed to investigate the expression of a novel lncRNA WW domain containing transcription regulator 1 antisense RNA 1 (WWTR1‐AS1) as well as its clinical significance and biological roles in HNSCC. The expression level of endogenous WWTR1‐AS1 in primary HNSCC and paired adjacent nontumor mucosa was evaluated by quantitative reverse‐transcription polymerase chain reaction. The correlations were assessed between WWTR1‐AS1 expression and clinical data such as clinicopathological parameters and patient survival. Further, the molecular mechanisms of WWTR1‐AS1 underlying HNSCC progression were detected by loss‐of‐function assay in vitro and bioinformatics analysis. Aberrant overexpression of WWTR1‐AS1 in HNSCC samples showed a significant correlation between its higher expression levels and larger tumor size, cervical node metastasis, and poor prognosis. WWTR1‐AS1 knockdown mediated by antisense oligonucleotide markedly inhibited cell proliferation, migration, invasion, tumorsphere formation as well as apoptosis resistance probably by modulating WWTR1 messenger RNA (mRNA) stability in HNSCC cells. Bioinformatics analysis revealed that WWTR1‐AS1 expression positively correlated with WWTR1 expression in TCGA‐HNSCC data sets. Together, our data provide evidence that aberrant upregulation of WWTR1‐AS1 associates with malignant features and unfavorable prognosis in HNSCC, highlighting that WWTR1‐AS1 might be a potential oncogenic lncRNA during HNSCC progression.

Context-dependent roles of YAP/TAZ in stem cell fates and cancer

“…For example, miR-550-1 targets TAZ in acute myeloid leukemia [ 112 ] and miR-455-3p targets TAZ in pancreatic cancer [ 182 ]. Notably, unlike YAP, TAZ has a natural antisense transcript known as WWTR1-AS1; knockdown of this transcript in head–neck squamous cell carcinoma reduces TAZ expression and increases apoptosis [ 183 ]. Though YAP and TAZ are rarely compared in parallel in any given cancer study, it has been shown that TAZ, but not YAP, is upregulated in alveolar rhabdomyosarcoma, and its depletion induces apoptosis and reduces xenograft growth [ 184 ].…”

The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1

“…In recent years, more and more studies have focused on lncRNAs as tumor diagnostic markers and potential therapeutic targets. Numerous researches have shown that lncRNAs play an important regulatory role in the development of various cancers, including glioma [ 3–5 ]. For example, linc00319 expresses at a high level in glioma and is significantly associated with poor prognosis of glioma patients, while knockdown of linc00319 impairs cell proliferation, arrests cell cycle and induces cell apoptosis of glioma cells [ 6 ].…”

A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK‐3β pathway

“…15 Hardly any reports are available so far on the aberrant lncRNAs implicated in the cellular dysfunction and signaling pathway of OPMD, despite aberrant lncRNAs having been implicated in the biological behavior of OSCC. [16][17][18][19][20][21] For instance, lncRNA AC007271.3 promotes cell proliferation, invasion, migration, and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway. 16 LncRNA LINC00961 inhibited cell proliferation and invasion of OSCC through the Wnt/β-catenin signaling pathway.…”